1	1	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Introduction	_	_	NN	_	_	_	_	_


1	Acrylamide	_	_	NNP	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	a	_	_	DT	_	_	_	_	_
4	thermal	_	_	JJ	_	_	_	_	_
5	processing	_	_	NN	_	_	_	_	_
6	contaminant	_	_	NN	_	_	_	_	_
7	with	_	_	IN	_	_	_	_	_
8	a	_	_	DT	_	_	_	_	_
9	low	_	_	JJ	_	_	_	_	_
10	molecular	_	_	JJ	_	_	_	_	_
11	weight	_	_	NN	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	which	_	_	WDT	_	_	_	_	_
14	is	_	_	VBZ	_	_	_	_	_
15	soluble	_	_	JJ	_	_	_	_	_
16	in	_	_	IN	_	_	_	_	_
17	water	_	_	NN	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	is	_	_	VBZ	_	_	_	_	_
20	formed	_	_	VBN	_	_	_	_	_
21	when	_	_	WRB	_	_	_	_	_
22	carbohydrate-rich	_	_	JJ	_	_	_	_	_
23	foods	_	_	NNS	_	_	_	_	_
24	are	_	_	VBP	_	_	_	_	_
25	subjected	_	_	VBN	_	_	_	_	_
26	to	_	_	TO	_	_	_	_	_
27	temperatures	_	_	NNS	_	_	_	_	_
28	above	_	_	IN	_	_	_	_	_
29	120	_	_	CD	_	_	_	_	_
30	°C	_	_	NNS	_	_	_	_	_
31	in	_	_	IN	_	_	_	_	_
32	low-moisture	_	_	JJ	_	_	_	_	_
33	conditions	_	_	NNS	_	_	_	_	_
34	,	_	_	,	_	_	_	_	_
35	such	_	_	JJ	_	_	_	_	_
36	as	_	_	IN	_	_	_	_	_
37	frying	_	_	NN	_	_	_	_	_
38	,	_	_	,	_	_	_	_	_
39	roasting	_	_	VBG	_	_	_	_	_
40	or	_	_	CC	_	_	_	_	_
41	baking	_	_	NN	_	_	_	_	_
42	.	_	_	.	_	_	_	_	_


1	Several	_	_	JJ	_	_	_	_	_
2	studies	_	_	NNS	_	_	_	_	_
3	consider	_	_	VBP	_	_	_	_	_
4	Maillard	_	_	NNP	_	_	_	_	_
5	reactions	_	_	NNS	_	_	_	_	_
6	to	_	_	TO	_	_	_	_	_
7	be	_	_	VB	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	main	_	_	JJ	_	_	_	_	_
10	pathway	_	_	NN	_	_	_	_	_
11	for	_	_	IN	_	_	_	_	_
12	acrylamide	_	_	NN	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	5	_	_	CD	_	_	_	_	_
15	hydroxymethylfurfural	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	methylglyoxal	_	_	NN	_	_	_	_	_
18	–	_	_	:	_	_	_	_	_
19	lysine	_	_	NN	_	_	_	_	_
20	dimers	_	_	NNS	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	Nε	_	_	NN	_	_	_	_	_
23	–	_	_	:	_	_	_	_	_
24	carboxymethyl	_	_	NN	_	_	_	_	_
25	–	_	_	:	_	_	_	_	_
26	lysine	_	_	NN	_	_	_	_	_
27	and	_	_	CC	_	_	_	_	_
28	pyrraline	_	_	NN	_	_	_	_	_
29	formation	_	_	NN	_	_	_	_	_
30	in	_	_	IN	_	_	_	_	_
31	processed	_	_	VBN	_	_	_	_	_
32	foods	_	_	NNS	_	_	_	_	_
33	,	_	_	,	_	_	_	_	_
34	particularly	_	_	RB	_	_	_	_	_
35	reactions	_	_	NNS	_	_	_	_	_
36	between	_	_	IN	_	_	_	_	_
37	the	_	_	DT	_	_	_	_	_
38	carbonyl	_	_	NN	_	_	_	_	_
39	group	_	_	NN	_	_	_	_	_
40	of	_	_	IN	_	_	_	_	_
41	reducing	_	_	VBG	_	_	_	_	_
42	sugars	_	_	NNS	_	_	_	_	_
43	and	_	_	CC	_	_	_	_	_
44	amino	_	_	NN	_	_	_	_	_
45	acids	_	_	NNS	_	_	_	_	_
46	.	_	_	.	_	_	_	_	_


1	Initial	_	_	JJ	_	_	_	_	_
2	reports	_	_	NNS	_	_	_	_	_
3	showed	_	_	VBD	_	_	_	_	_
4	relatively	_	_	RB	_	_	_	_	_
5	high	_	_	JJ	_	_	_	_	_
6	concentrations	_	_	NNS	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	acrylamide	_	_	NN	_	_	_	_	_
9	in	_	_	IN	_	_	_	_	_
10	high-carbohydrate	_	_	JJ	_	_	_	_	_
11	foodstuffs	_	_	NNS	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	such	_	_	JJ	_	_	_	_	_
14	as	_	_	IN	_	_	_	_	_
15	crispy	_	_	JJ	_	_	_	_	_
16	bread	_	_	NN	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	breakfast	_	_	NN	_	_	_	_	_
19	cereals	_	_	NNS	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	pastries	_	_	NNS	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	coffee	_	_	NN	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	French	_	_	JJ	_	_	_	_	_
26	fries	_	_	NNS	_	_	_	_	_
27	and	_	_	CC	_	_	_	_	_
28	crisps	_	_	NNS	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	general	_	_	JJ	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	potato	_	_	NN	_	_	_	_	_
5	products	_	_	NNS	_	_	_	_	_
6	present	_	_	VBP	_	_	_	_	_
7	higher	_	_	JJR	_	_	_	_	_
8	acrylamide	_	_	NN	_	_	_	_	_
9	contents	_	_	NNS	_	_	_	_	_
10	(	_	_	-LRB-	_	_	_	_	_
11	250	_	_	CD	_	_	_	_	_
12	–	_	_	TO	_	_	_	_	_
13	4000	_	_	CD	_	_	_	_	_
14	µg	_	_	NN	_	_	_	_	_
15	kg−1	_	_	NN	_	_	_	_	_
16	)	_	_	-RRB-	_	_	_	_	_
17	compared	_	_	VBN	_	_	_	_	_
18	to	_	_	TO	_	_	_	_	_
19	other	_	_	JJ	_	_	_	_	_
20	food	_	_	NN	_	_	_	_	_
21	products	_	_	NNS	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	because	_	_	IN	_	_	_	_	_
24	of	_	_	IN	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	higher	_	_	JJR	_	_	_	_	_
27	concentration	_	_	NN	_	_	_	_	_
28	of	_	_	IN	_	_	_	_	_
29	asparagine	_	_	NN	_	_	_	_	_
30	in	_	_	IN	_	_	_	_	_
31	potato	_	_	NN	_	_	_	_	_
32	tubers	_	_	NNS	_	_	_	_	_
33	.	_	_	.	_	_	_	_	_


1	Acrylamide	_	_	NNP	_	_	_	_	_
2	has	_	_	VBZ	_	_	_	_	_
3	been	_	_	VBN	_	_	_	_	_
4	classified	_	_	VBN	_	_	_	_	_
5	by	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	Agency	_	_	NNP	_	_	_	_	_
8	for	_	_	IN	_	_	_	_	_
9	Research	_	_	NNP	_	_	_	_	_
10	on	_	_	IN	_	_	_	_	_
11	Cancer	_	_	NNP	_	_	_	_	_
12	as	_	_	IN	_	_	_	_	_
13	“	_	_	``	_	_	_	_	_
14	probably	_	_	RB	_	_	_	_	_
15	carcinogenic	_	_	JJ	_	_	_	_	_
16	to	_	_	TO	_	_	_	_	_
17	humans	_	_	NNS	_	_	_	_	_
18	”	_	_	''	_	_	_	_	_
19	(	_	_	-LRB-	_	_	_	_	_
20	Group	_	_	NNP	_	_	_	_	_
21	2A	_	_	NNP	_	_	_	_	_
22	)	_	_	-RRB-	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	in	_	_	IN	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	latest	_	_	JJS	_	_	_	_	_
28	report	_	_	NN	_	_	_	_	_
29	from	_	_	IN	_	_	_	_	_
30	the	_	_	DT	_	_	_	_	_
31	European	_	_	NNP	_	_	_	_	_
32	Food	_	_	NNP	_	_	_	_	_
33	Safety	_	_	NNP	_	_	_	_	_
34	Authority	_	_	NNP	_	_	_	_	_
35	Expert	_	_	NNP	_	_	_	_	_
36	Panel	_	_	NNP	_	_	_	_	_
37	on	_	_	IN	_	_	_	_	_
38	Contaminants	_	_	NNPS	_	_	_	_	_
39	in	_	_	IN	_	_	_	_	_
40	the	_	_	DT	_	_	_	_	_
41	Food	_	_	NNP	_	_	_	_	_
42	Chain	_	_	NNP	_	_	_	_	_
43	(	_	_	-LRB-	_	_	_	_	_
44	CONTAM	_	_	NNP	_	_	_	_	_
45	,	_	_	,	_	_	_	_	_
46	2015	_	_	CD	_	_	_	_	_
47	)	_	_	-RRB-	_	_	_	_	_
48	,	_	_	,	_	_	_	_	_
49	the	_	_	DT	_	_	_	_	_
50	margins	_	_	NNS	_	_	_	_	_
51	of	_	_	IN	_	_	_	_	_
52	exposure	_	_	NN	_	_	_	_	_
53	for	_	_	IN	_	_	_	_	_
54	acrylamide	_	_	NN	_	_	_	_	_
55	lead	_	_	VBP	_	_	_	_	_
56	to	_	_	TO	_	_	_	_	_
57	concerns	_	_	NNS	_	_	_	_	_
58	regarding	_	_	VBG	_	_	_	_	_
59	their	_	_	PRP$	_	_	_	_	_
60	neoplastic	_	_	JJ	_	_	_	_	_
61	effects	_	_	NNS	_	_	_	_	_
62	,	_	_	,	_	_	_	_	_
63	based	_	_	VBN	_	_	_	_	_
64	on	_	_	IN	_	_	_	_	_
65	animal	_	_	NN	_	_	_	_	_
66	evidence	_	_	NN	_	_	_	_	_
67	.	_	_	.	_	_	_	_	_


1	Therefore	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	European	_	_	NNP	_	_	_	_	_
5	Commission	_	_	NNP	_	_	_	_	_
6	recently	_	_	RB	_	_	_	_	_
7	established	_	_	VBD	_	_	_	_	_
8	“	_	_	``	_	_	_	_	_
9	indicative	_	_	JJ	_	_	_	_	_
10	”	_	_	''	_	_	_	_	_
11	levels	_	_	NNS	_	_	_	_	_
12	for	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	presence	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	acrylamide	_	_	NN	_	_	_	_	_
17	in	_	_	IN	_	_	_	_	_
18	food	_	_	NN	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	suggesting	_	_	VBG	_	_	_	_	_
21	a	_	_	DT	_	_	_	_	_
22	limit	_	_	NN	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	750	_	_	CD	_	_	_	_	_
25	µg	_	_	NN	_	_	_	_	_
26	kg−1	_	_	NNS	_	_	_	_	_
27	for	_	_	IN	_	_	_	_	_
28	crisps	_	_	NNS	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	Previously	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	European	_	_	NNP	_	_	_	_	_
5	Union	_	_	NNP	_	_	_	_	_
6	and	_	_	CC	_	_	_	_	_
7	FDA	_	_	NNP	_	_	_	_	_
8	had	_	_	VBD	_	_	_	_	_
9	encouraged	_	_	VBN	_	_	_	_	_
10	food	_	_	NN	_	_	_	_	_
11	industries	_	_	NNS	_	_	_	_	_
12	to	_	_	TO	_	_	_	_	_
13	reduce	_	_	VB	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	presence	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	this	_	_	DT	_	_	_	_	_
18	contaminant	_	_	NN	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	response	_	_	NN	_	_	_	_	_
3	to	_	_	TO	_	_	_	_	_
4	this	_	_	DT	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	food	_	_	NN	_	_	_	_	_
8	industry	_	_	NN	_	_	_	_	_
9	has	_	_	VBZ	_	_	_	_	_
10	been	_	_	VBN	_	_	_	_	_
11	forced	_	_	VBN	_	_	_	_	_
12	to	_	_	TO	_	_	_	_	_
13	apply	_	_	VB	_	_	_	_	_
14	different	_	_	JJ	_	_	_	_	_
15	strategies	_	_	NNS	_	_	_	_	_
16	to	_	_	TO	_	_	_	_	_
17	reduce	_	_	VB	_	_	_	_	_
18	acrylamide	_	_	NN	_	_	_	_	_
19	formation	_	_	NN	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	applying	_	_	VBG	_	_	_	_	_
22	processing	_	_	VBG	_	_	_	_	_
23	modifications	_	_	NNS	_	_	_	_	_
24	according	_	_	VBG	_	_	_	_	_
25	to	_	_	TO	_	_	_	_	_
26	recommendations	_	_	NNS	_	_	_	_	_
27	published	_	_	VBN	_	_	_	_	_
28	by	_	_	IN	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	European	_	_	NNP	_	_	_	_	_
31	Food	_	_	NNP	_	_	_	_	_
32	and	_	_	CC	_	_	_	_	_
33	Drink	_	_	NNP	_	_	_	_	_
34	Federation	_	_	NNP	_	_	_	_	_
35	in	_	_	IN	_	_	_	_	_
36	the	_	_	DT	_	_	_	_	_
37	document	_	_	NN	_	_	_	_	_
38	“	_	_	``	_	_	_	_	_
39	Acrylamide	_	_	NNP	_	_	_	_	_
40	Toolbox	_	_	NNP	_	_	_	_	_
41	”	_	_	''	_	_	_	_	_
42	,	_	_	,	_	_	_	_	_
43	which	_	_	WDT	_	_	_	_	_
44	includes	_	_	VBZ	_	_	_	_	_
45	the	_	_	DT	_	_	_	_	_
46	following	_	_	VBG	_	_	_	_	_
47	variables	_	_	NNS	_	_	_	_	_
48	:	_	_	:	_	_	_	_	_
49	temperature	_	_	NN	_	_	_	_	_
50	and	_	_	CC	_	_	_	_	_
51	time	_	_	NN	_	_	_	_	_
52	during	_	_	IN	_	_	_	_	_
53	frying	_	_	NN	_	_	_	_	_
54	,	_	_	,	_	_	_	_	_
55	blanching	_	_	NN	_	_	_	_	_
56	treatment	_	_	NN	_	_	_	_	_
57	,	_	_	,	_	_	_	_	_
58	and	_	_	CC	_	_	_	_	_
59	thickness	_	_	NN	_	_	_	_	_
60	of	_	_	IN	_	_	_	_	_
61	potato	_	_	NN	_	_	_	_	_
62	slices	_	_	NNS	_	_	_	_	_
63	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	main	_	_	JJ	_	_	_	_	_
5	challenge	_	_	NN	_	_	_	_	_
6	for	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	food	_	_	NN	_	_	_	_	_
9	industries	_	_	NNS	_	_	_	_	_
10	is	_	_	VBZ	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	producing	_	_	VBG	_	_	_	_	_
13	potato	_	_	NN	_	_	_	_	_
14	chips	_	_	NNS	_	_	_	_	_
15	with	_	_	IN	_	_	_	_	_
16	low	_	_	JJ	_	_	_	_	_
17	acrylamide	_	_	NN	_	_	_	_	_
18	levels	_	_	NNS	_	_	_	_	_
19	without	_	_	IN	_	_	_	_	_
20	affecting	_	_	VBG	_	_	_	_	_
21	their	_	_	PRP$	_	_	_	_	_
22	sensory	_	_	JJ	_	_	_	_	_
23	properties	_	_	NNS	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_


1	Although	_	_	IN	_	_	_	_	_
2	it	_	_	PRP	_	_	_	_	_
3	is	_	_	VBZ	_	_	_	_	_
4	important	_	_	JJ	_	_	_	_	_
5	to	_	_	TO	_	_	_	_	_
6	evaluate	_	_	VB	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	effect	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	pre-treatments	_	_	NNS	_	_	_	_	_
11	on	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	frying	_	_	NN	_	_	_	_	_
14	process	_	_	NN	_	_	_	_	_
15	on	_	_	IN	_	_	_	_	_
16	acrylamide	_	_	NN	_	_	_	_	_
17	mitigation	_	_	NN	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	it	_	_	PRP	_	_	_	_	_
20	is	_	_	VBZ	_	_	_	_	_
21	also	_	_	RB	_	_	_	_	_
22	necessary	_	_	JJ	_	_	_	_	_
23	to	_	_	TO	_	_	_	_	_
24	determine	_	_	VB	_	_	_	_	_
25	their	_	_	PRP$	_	_	_	_	_
26	influence	_	_	NN	_	_	_	_	_
27	on	_	_	IN	_	_	_	_	_
28	its	_	_	PRP$	_	_	_	_	_
29	bioavailability	_	_	NN	_	_	_	_	_
30	.	_	_	.	_	_	_	_	_


1	Potato	_	_	NN	_	_	_	_	_
2	chips	_	_	NNS	_	_	_	_	_
3	are	_	_	VBP	_	_	_	_	_
4	an	_	_	DT	_	_	_	_	_
5	important	_	_	JJ	_	_	_	_	_
6	part	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	snack	_	_	NN	_	_	_	_	_
10	food	_	_	NN	_	_	_	_	_
11	market	_	_	NN	_	_	_	_	_
12	in	_	_	IN	_	_	_	_	_
13	many	_	_	JJ	_	_	_	_	_
14	countries	_	_	NNS	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	and	_	_	CC	_	_	_	_	_
17	few	_	_	JJ	_	_	_	_	_
18	studies	_	_	NNS	_	_	_	_	_
19	have	_	_	VBP	_	_	_	_	_
20	been	_	_	VBN	_	_	_	_	_
21	published	_	_	VBN	_	_	_	_	_
22	about	_	_	IN	_	_	_	_	_
23	the	_	_	DT	_	_	_	_	_
24	bioavailability	_	_	NN	_	_	_	_	_
25	of	_	_	IN	_	_	_	_	_
26	acrylamide	_	_	NN	_	_	_	_	_
27	after	_	_	IN	_	_	_	_	_
28	crisps	_	_	NNS	_	_	_	_	_
29	have	_	_	VBP	_	_	_	_	_
30	been	_	_	VBN	_	_	_	_	_
31	through	_	_	IN	_	_	_	_	_
32	the	_	_	DT	_	_	_	_	_
33	digestion	_	_	NN	_	_	_	_	_
34	process	_	_	NN	_	_	_	_	_
35	.	_	_	.	_	_	_	_	_


1	Acrylamide	_	_	NN	_	_	_	_	_
2	intake	_	_	NN	_	_	_	_	_
3	in	_	_	IN	_	_	_	_	_
4	humans	_	_	NNS	_	_	_	_	_
5	occurs	_	_	VBZ	_	_	_	_	_
6	mainly	_	_	RB	_	_	_	_	_
7	via	_	_	IN	_	_	_	_	_
8	food	_	_	NN	_	_	_	_	_
9	ingestion	_	_	NN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	where	_	_	WRB	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	total	_	_	JJ	_	_	_	_	_
14	amount	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	this	_	_	DT	_	_	_	_	_
17	compound	_	_	NN	_	_	_	_	_
18	does	_	_	VBZ	_	_	_	_	_
19	not	_	_	RB	_	_	_	_	_
20	necessarily	_	_	RB	_	_	_	_	_
21	reflect	_	_	VB	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	available	_	_	JJ	_	_	_	_	_
24	amount	_	_	NN	_	_	_	_	_
25	to	_	_	TO	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	body	_	_	NN	_	_	_	_	_
28	.	_	_	.	_	_	_	_	_


1	There	_	_	EX	_	_	_	_	_
2	are	_	_	VBP	_	_	_	_	_
3	chemical	_	_	JJ	_	_	_	_	_
4	changes	_	_	NNS	_	_	_	_	_
5	in	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	food	_	_	NN	_	_	_	_	_
8	when	_	_	WRB	_	_	_	_	_
9	it	_	_	PRP	_	_	_	_	_
10	enters	_	_	VBZ	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	digestive	_	_	JJ	_	_	_	_	_
13	tract	_	_	NN	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	because	_	_	IN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	pH	_	_	NN	_	_	_	_	_
18	variations	_	_	NNS	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	the	_	_	DT	_	_	_	_	_
22	action	_	_	NN	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	several	_	_	JJ	_	_	_	_	_
25	enzymes	_	_	NNS	_	_	_	_	_
26	in	_	_	IN	_	_	_	_	_
27	every	_	_	DT	_	_	_	_	_
28	stage	_	_	NN	_	_	_	_	_
29	of	_	_	IN	_	_	_	_	_
30	the	_	_	DT	_	_	_	_	_
31	digestion	_	_	NN	_	_	_	_	_
32	process	_	_	NN	_	_	_	_	_
33	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	this	_	_	DT	_	_	_	_	_
3	sense	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	bioaccessibility	_	_	NN	_	_	_	_	_
6	is	_	_	VBZ	_	_	_	_	_
7	used	_	_	VBN	_	_	_	_	_
8	to	_	_	TO	_	_	_	_	_
9	evaluate	_	_	VB	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	amount	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	a	_	_	DT	_	_	_	_	_
14	chemical	_	_	JJ	_	_	_	_	_
15	compound	_	_	NN	_	_	_	_	_
16	available	_	_	JJ	_	_	_	_	_
17	for	_	_	IN	_	_	_	_	_
18	absorption	_	_	NN	_	_	_	_	_
19	after	_	_	IN	_	_	_	_	_
20	it	_	_	PRP	_	_	_	_	_
21	is	_	_	VBZ	_	_	_	_	_
22	released	_	_	VBN	_	_	_	_	_
23	from	_	_	IN	_	_	_	_	_
24	the	_	_	DT	_	_	_	_	_
25	food	_	_	NN	_	_	_	_	_
26	matrix	_	_	NN	_	_	_	_	_
27	into	_	_	IN	_	_	_	_	_
28	the	_	_	DT	_	_	_	_	_
29	gastrointestinal	_	_	JJ	_	_	_	_	_
30	tract	_	_	NN	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	Several	_	_	JJ	_	_	_	_	_
2	methodologies	_	_	NNS	_	_	_	_	_
3	can	_	_	MD	_	_	_	_	_
4	be	_	_	VB	_	_	_	_	_
5	used	_	_	VBN	_	_	_	_	_
6	to	_	_	TO	_	_	_	_	_
7	assess	_	_	VB	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	bioaccessibility	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	contaminants	_	_	NNS	_	_	_	_	_
12	or	_	_	CC	_	_	_	_	_
13	nutrients	_	_	NNS	_	_	_	_	_
14	:	_	_	:	_	_	_	_	_
15	1	_	_	CD	_	_	_	_	_
16	)	_	_	-RRB-	_	_	_	_	_
17	in	_	_	IN	_	_	_	_	_
18	vitro	_	_	NN	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	2	_	_	CD	_	_	_	_	_
21	)	_	_	-RRB-	_	_	_	_	_
22	ex	_	_	JJ	_	_	_	_	_
23	vivo	_	_	NN	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	3	_	_	CD	_	_	_	_	_
26	)	_	_	-RRB-	_	_	_	_	_
27	in	_	_	IN	_	_	_	_	_
28	situ	_	_	NN	_	_	_	_	_
29	and	_	_	CC	_	_	_	_	_
30	4	_	_	CD	_	_	_	_	_
31	)	_	_	-RRB-	_	_	_	_	_
32	in	_	_	IN	_	_	_	_	_
33	vivo	_	_	NN	_	_	_	_	_
34	models	_	_	NNS	_	_	_	_	_
35	.	_	_	.	_	_	_	_	_


1	Among	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	techniques	_	_	NNS	_	_	_	_	_
4	mentioned	_	_	VBN	_	_	_	_	_
5	before	_	_	RB	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	vitro	_	_	NN	_	_	_	_	_
9	models	_	_	NNS	_	_	_	_	_
10	are	_	_	VBP	_	_	_	_	_
11	more	_	_	RBR	_	_	_	_	_
12	commonly	_	_	RB	_	_	_	_	_
13	used	_	_	VBN	_	_	_	_	_
14	than	_	_	IN	_	_	_	_	_
15	in	_	_	IN	_	_	_	_	_
16	vivo	_	_	NN	_	_	_	_	_
17	models	_	_	NNS	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	because	_	_	IN	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	their	_	_	PRP$	_	_	_	_	_
22	simplicity	_	_	NN	_	_	_	_	_
23	,	_	_	,	_	_	_	_	_
24	lower	_	_	JJR	_	_	_	_	_
25	cost	_	_	NN	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	lack	_	_	NN	_	_	_	_	_
28	of	_	_	IN	_	_	_	_	_
29	ethical	_	_	JJ	_	_	_	_	_
30	issues	_	_	NNS	_	_	_	_	_
31	and	_	_	CC	_	_	_	_	_
32	good	_	_	JJ	_	_	_	_	_
33	reproducibility	_	_	NN	_	_	_	_	_
34	under	_	_	IN	_	_	_	_	_
35	controlled	_	_	VBN	_	_	_	_	_
36	conditions	_	_	NNS	_	_	_	_	_
37	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	present	_	_	JJ	_	_	_	_	_
3	work	_	_	NN	_	_	_	_	_
4	evaluated	_	_	VBD	_	_	_	_	_
5	some	_	_	DT	_	_	_	_	_
6	acrylamide	_	_	NN	_	_	_	_	_
7	mitigation	_	_	NN	_	_	_	_	_
8	strategies	_	_	NNS	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	employing	_	_	VBG	_	_	_	_	_
11	a	_	_	DT	_	_	_	_	_
12	fractional	_	_	JJ	_	_	_	_	_
13	factorial	_	_	JJ	_	_	_	_	_
14	design	_	_	NN	_	_	_	_	_
15	experiment	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	their	_	_	PRP$	_	_	_	_	_
19	influence	_	_	NN	_	_	_	_	_
20	on	_	_	IN	_	_	_	_	_
21	textural	_	_	JJ	_	_	_	_	_
22	properties	_	_	NNS	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	bioaccesibility	_	_	NN	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	by	_	_	IN	_	_	_	_	_
27	an	_	_	DT	_	_	_	_	_
28	in	_	_	IN	_	_	_	_	_
29	vitro	_	_	NN	_	_	_	_	_
30	simulated	_	_	VBN	_	_	_	_	_
31	digestion	_	_	NN	_	_	_	_	_
32	assay	_	_	NN	_	_	_	_	_
33	.	_	_	.	_	_	_	_	_

